EVOK
Price
$5.21
Change
-$0.08 (-1.51%)
Updated
Sep 5 closing price
Capitalization
8.24M
PRFX
Price
$1.42
Change
-$0.20 (-12.35%)
Updated
Sep 5 closing price
Capitalization
3.27M
68 days until earnings call
Interact to see
Advertisement

EVOK vs PRFX

Header iconEVOK vs PRFX Comparison
Open Charts EVOK vs PRFXBanner chart's image
Evoke Pharma
Price$5.21
Change-$0.08 (-1.51%)
Volume$9.72K
Capitalization8.24M
PainReform
Price$1.42
Change-$0.20 (-12.35%)
Volume$460.2K
Capitalization3.27M
EVOK vs PRFX Comparison Chart in %
Loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. PRFX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (EVOK: $5.21 vs. PRFX: $1.42)
Brand notoriety: EVOK and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EVOK: 0% vs. PRFX: 11%
Market capitalization -- EVOK: $8.24M vs. PRFX: $3.27M
EVOK [@Pharmaceuticals: Generic] is valued at $8.24M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $3.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, EVOK is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 3 bullish TA indicator(s).

  • EVOK’s TA Score: 4 bullish, 4 bearish.
  • PRFX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, EVOK is a better buy in the short-term than PRFX.

Price Growth

EVOK (@Pharmaceuticals: Generic) experienced а -4.40% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVOK($8.24M) has a higher market cap than PRFX($3.27M). EVOK YTD gains are higher at: 17.873 vs. PRFX (-57.675). EVOK has higher annual earnings (EBITDA): -4.88M vs. PRFX (-17.81M). PRFX has less debt than EVOK: PRFX (59K) vs EVOK (5.13M). EVOK has higher revenues than PRFX: EVOK (12.8M) vs PRFX (0).
EVOKPRFXEVOK / PRFX
Capitalization8.24M3.27M252%
EBITDA-4.88M-17.81M27%
Gain YTD17.873-57.675-31%
P/E Ratio0.04N/A-
Revenue12.8M0-
Total Cash12.1MN/A-
Total Debt5.13M59K8,693%
FUNDAMENTALS RATINGS
EVOK: Fundamental Ratings
EVOK
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVOKPRFX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAER2.030.08
+4.10%
Bridger Aerospace Group Holdings
MPW4.610.16
+3.60%
Medical Properties Trust
OEC10.620.30
+2.91%
Orion SA
J145.421.68
+1.17%
Jacobs Solutions
FBGL0.55-0.02
-2.76%
FBS Global Ltd

EVOK and

Correlation & Price change

A.I.dvisor tells us that EVOK and RMTI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVOK and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVOK
1D Price
Change %
EVOK100%
-1.51%
RMTI - EVOK
28%
Poorly correlated
-3.57%
NBIX - EVOK
28%
Poorly correlated
+2.64%
EOLS - EVOK
26%
Poorly correlated
+2.00%
EVO - EVOK
24%
Poorly correlated
+3.26%
PRFX - EVOK
24%
Poorly correlated
-12.62%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and EVOK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and EVOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-12.62%
EVOK - PRFX
24%
Poorly correlated
-1.51%
AMRX - PRFX
24%
Poorly correlated
+0.73%
LFCR - PRFX
21%
Poorly correlated
-5.16%
AYURF - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
+1.13%
More